These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12963757)

  • 1. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD.
    Qiu C; Winblad B; Fastbom J; Fratiglioni L
    Neurology; 2003 Sep; 61(5):655-60. PubMed ID: 12963757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele.
    Rajan KB; Barnes LL; Wilson RS; Weuve J; McAninch EA; Evans DA
    Ann Neurol; 2018 May; 83(5):935-944. PubMed ID: 29637601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?
    Guo Z; Fratiglioni L; Viitanen M; Lannfelt L; Basun H; Fastbom J; Winblad B
    Am J Epidemiol; 2001 Feb; 153(3):225-31. PubMed ID: 11157409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study.
    Zhu L; Fratiglioni L; Guo Z; Basun H; Corder EH; Winblad B; Viitanen M
    Stroke; 2000 Jan; 31(1):53-60. PubMed ID: 10625715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
    Shah RC; Wilson RS; Bienias JL; Arvanitakis Z; Evans DA; Bennett DA
    Neuroepidemiology; 2006; 26(1):30-6. PubMed ID: 16254451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
    Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
    Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H
    Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
    Qiu C; Kivipelto M; Agüero-Torres H; Winblad B; Fratiglioni L
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):828-33. PubMed ID: 15145993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low diastolic pressure and risk of dementia in very old people: a longitudinal study.
    Qiu C; Winblad B; Fratiglioni L
    Dement Geriatr Cogn Disord; 2009; 28(3):213-9. PubMed ID: 19752556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
    Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
    Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.